Who has invested in Chime Biologics?

Panacea Venture are named among the investors backing Chime Biologics.

Chime Biologics Funding: $190M Raised, Series A (2021)

Chime Biologics funding overview

Chime Biologics is based in Shanghai, China. Chime Biologics has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Chime Biologics runs through 2021; nothing later has been disclosed. Investors on record include Panacea Venture.

Chime Biologics at a glance

Total raised: $190M
Latest round: Series A
Latest round date: January 2021
Headquarters: Shanghai, China
Notable investors: Panacea Venture

Frequently asked about Chime Biologics funding

How much has Chime Biologics raised?: Chime Biologics has raised $190M in total disclosed funding across the rounds on record.
Who has invested in Chime Biologics?: Panacea Venture are named among the investors backing Chime Biologics.
What was the latest Chime Biologics funding round?: The most recent disclosed round is a Series A, announced in January 2021.
Where is Chime Biologics based?: Chime Biologics is based in Shanghai, China.
When did Chime Biologics last raise?: The last disclosed Chime Biologics round closed in January 2021 at Series A.

Chime Biologics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

Chime Biologics Funding: $190M Raised, Series A (2021)

Chime Biologics funding overview

Chime Biologics at a glance

Frequently asked about Chime Biologics funding

Companies related to Chime Biologics (27)

Browse related funding lists (6)